TITAN PHARMACEUTICAL INC
TTP
TTP was delisted on the 24th of December, 2008.
1 hedge funds and large institutions have $4K invested in TITAN PHARMACEUTICAL INC in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
97% less capital invested
Capital invested by funds: $124K → $4K (-$120K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
-$116K |
TTP Hedge Fund Activity: Q2 2017 in Review
1 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in TITAN PHARMACEUTICAL INC (TTP) for Q2 2017, worth a combined $4K — down 97% from $124K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of TTP and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Gagnon Securities, exiting entirely with an estimated $116K sold.
- 1 institutional investor held TITAN PHARMACEUTICAL INC (TTP) as of Q2 2017, down from 2 in Q1 2017.
- Funds reported $4K of TITAN PHARMACEUTICAL INC stock for Q2 2017, down 97% quarter-over-quarter.
- 0 funds opened new TITAN PHARMACEUTICAL INC positions in Q2 2017 and 1 closed out, a net change of -1 holder.
- The largest TITAN PHARMACEUTICAL INC seller in Q2 2017 was Gagnon Securities, an estimated $116K sold.
Based on aggregated 13F filings for Q2 2017.